RECURRENT NEUROBLASTOMA

Clinical trials for RECURRENT NEUROBLASTOMA explained in plain language.

Never miss a new study

Get alerted when new RECURRENT NEUROBLASTOMA trials appear

Sign up with your email to follow new studies for RECURRENT NEUROBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 13 Completed 4 Terminated 1

New antibody cocktail takes aim at tough childhood cancers

Disease control Terminated

This early-phase trial tested two lab-made antibodies, magrolimab and dinutuximab, together in 12 children and young adults whose neuroblastoma or osteosarcoma had returned or stopped responding to treatment. The main goal was to find a safe dose and watch for side effects. Resea…

Matched conditions: RECURRENT NEUROBLASTOMA

Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Jul 02, 2026 00:00 UTC

RECURRENT NEUROBLASTOMA

Get alerted when new RECURRENT NEUROBLASTOMA trials appear

New antibody cocktail takes aim at tough childhood cancers